We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biora Therapeutics Inc | NASDAQ:PROG | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.8845 | 0.8845 | 0.89 | 0 | 01:00:00 |
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-258301
Prospectus Supplement
(To Prospectus dated August 6, 2021)
This prospectus supplement supplements and amends the prospectus dated August 6, 2021 (the Prospectus), as supplemented and amended by (i) that certain prospectus supplement dated November 22, 2021 covering the offering, issuance and sale of up to a maximum aggregate offering price of $90,000,000 of our common stock that may be issued and sold under a sales agreement with B. Riley Securities, Inc., BTIG, LLC and H.C. Wainwright & Co., LLC (the ATM Facility), and (ii) that certain prospectus supplement dated November 7, 2022 reducing the maximum aggregate offering price of the ATM Facility to $70,000,000 (the Maximum Offering Price).
Effective as of June 13, 2023, we have reduced the Maximum Offering Price to $12,000,000. As of the date of this prospectus supplement, 12,545,741 shares have been sold under the ATM Facility.
You should read this prospectus supplement, together with additional information described under the headings Information Incorporated by Reference and Where You Can Find Additional Information in the Prospectus carefully before you invest in our securities.
Investing in our securities involves a high degree of risk. Before making any investment in our securities, you should consider carefully the risks and uncertainties described in the section entitled Risk Factors beginning on page 2 of the Prospectus.
The date of this prospectus supplement is June 13, 2023.
1 Year Biora Therapeutics Chart |
1 Month Biora Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions